

Cover Story
By Matthew Bin Han Ong
In an era of intensifying judicial repudiation of evidence-based guidelines and deepening public mistrust toward science, America’s screening rate for cervical cancer has been declining.
In Brief


Clinical Roundup


Drugs & Targets
Trending Stories
- House passes three-year extension of ACA subsidies with bipartisan support
- A planned randomized trial will ask an intriguing question: Do COVID vaccines potentiate checkpoint inhibitors?
- MSK’s AML researcher Bayard “Barney” Clarkson, former president of ASCO and AACR, dies at 99
- NIH agrees to review hundreds of denied or shelved grant applications
- Patient advocate David Mitchell, 75, dies of multiple myeloma
- Paul Engstrom, Fox Chase pioneer of cancer prevention, dies at 89
















